Is Mounjaro Available on NHS Scotland — and What Are the Alternatives?

You've searched this because Scotland's rules aren't the same as England's

Imagine you've heard colleagues in England talking about getting tirzepatide through their GP under the new NHS contract. You're in Edinburgh or Inverness, wondering whether the same door is open to you. The short answer is: not quite, and here is why.

In England, NICE published its appraisal of tirzepatide for weight management (TA1026) in December 2024, and NHS England has been rolling out access in phases since mid-2025. That appraisal is an England-and-Wales recommendation. Scotland has its own body, the Scottish Medicines Consortium (SMC), which assesses medicines independently for NHS Scotland. Until the SMC publishes an accepted recommendation specifically for tirzepatide in weight management, routine NHS Scotland prescribing sits on a different footing. Some patients may access it through exceptional prescribing channels, but those routes are narrow and clinician-led.

For a fuller picture of how NHS access for tirzepatide is structured across the UK, this page on tirzepatide NHS access covers the England phases and the wider picture in plain language.

What NHS Scotland's weight-management pathway actually looks like

NHS Scotland funds specialist weight-management services, and within those services clinicians can and do prescribe medicines for obesity. The pathway typically involves referral from a GP, an assessment by a multidisciplinary team, and ongoing support, not a quick prescription at the counter.

NHSinform Scotland notes that diabetes and weight-loss medications are assessed and prescribed within these specialist pathways, and that clinical criteria govern access. In practice, that means patients often wait months before a first appointment, and not every health board has uniform provision. Rural boards in particular have reported capacity constraints.

For people who do not yet meet the criteria for an NHS Scotland specialist referral, or who have been referred but face a significant wait, a private prescription through a regulated pharmacy is the other legal route. Read more about how a Mounjaro prescription works in Scotland if you're weighing that option. Worth noting: private treatment does not affect your place on any NHS waiting list, the two run in parallel.

Scotland also operates under SIGN guidelines for obesity management, and clinicians will weigh those alongside any emerging national guidance on weight-management medicines. The landscape is moving; what applies today may look different in twelve months.

The licensed eligibility criteria that apply regardless of route

Whichever route you pursue, the medicine's UK licence sets the floor. Tirzepatide is licensed for weight management in adults with a BMI of 30 or above, or 27 or above when at least one weight-related condition is present, such as high blood pressure, raised cholesterol, type 2 diabetes or obstructive sleep apnoea. For some ethnic backgrounds, UK guidance applies thresholds 2.5 kg/m² lower; the detail on Scottish NHS eligibility for Mounjaro covers those adjustments clearly.

BMI alone does not guarantee a prescription. A prescriber looks at the whole clinical picture: other medicines you take, your history, any contraindications. If you are also wondering whether Mounjaro is available on the NHS, that page sets out the current position across the UK clearly, including the eligibility criteria prescribers apply. Pregnancy, breastfeeding, and planning to conceive are all situations where tirzepatide is not recommended; under-18s are outside the licensed indication entirely.

For context on how the two main injectable weight-loss medicines compare for people weighing up their options, the treatment overview page sets out what is currently licensed in the UK.

Private prescription in Scotland: what the process looks like

If you can't access NHS Scotland treatment, or if the wait doesn't work for your situation right now, a private prescription from a GPhC-registered online pharmacy is a legitimate and fully regulated route. The process is straightforward: you complete a clinical consultation, a GPhC-registered Independent Prescriber reviews your answers (a real clinician reads your case, not automated software), and if you're clinically suitable you receive a prescription and your treatment is dispatched.

You can verify any online pharmacy on the GPhC's public register. It takes thirty seconds and is worth doing before committing to any provider. A pharmacy registered there is regulated to the same standards as your local high-street chemist.

The cost of private treatment is real and worth understanding honestly. Since Eli Lilly revised its UK list price in September 2025, private market prices for tirzepatide have broadly ranged from around £149 to £375 per month depending on dose and provider, as widely reported. This page on buying Mounjaro explains what an honest price includes and what to watch out for. Discount codes for prescription medicines from unverified sellers are a red flag, not a saving; the MHRA has warned repeatedly about counterfeit GLP-1 pens circulating online and via social media.

At nume, treatment is reviewed the same day by a GPhC-registered prescriber. Order before noon on a weekday and, once clinically approved, your treatment leaves our pharmacy the same day via tracked DPD delivery, arriving free the next working day in plain packaging, some people time it so the pen is in the fridge before they need to think about it again. If you'd like to speak to our prescribers and find out whether treatment is suitable for you, start your free consultation here.